|
TRIM6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.539100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.157910E-02 |
| Normal-vs-Stage2 |
1.835900E-02 |
| Normal-vs-Stage3 |
2.860300E-03 |
| Normal-vs-Stage4 |
2.976600E-03 |
| Stage1-vs-Stage2 |
8.362600E-01 |
| Stage1-vs-Stage3 |
1.786050E-01 |
| Stage1-vs-Stage4 |
2.187000E-01 |
| Stage2-vs-Stage3 |
2.067000E-01 |
| Stage2-vs-Stage4 |
2.751600E-01 |
| Stage3-vs-Stage4 |
8.236800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.197700E-03 |
| Normal-vs-AfricanAmerican |
6.776300E-03 |
| Normal-vs-Asian |
2.565000E-01 |
| Caucasian-vs-AfricanAmerican |
9.337000E-01 |
| Caucasian-vs-Asian |
8.490800E-01 |
| AfricanAmerican-vs-Asian |
7.230400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.695400E-03 |
| Normal-vs-Female |
4.775300E-03 |
| Male-vs-Female |
5.118600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.820700E-03 |
| Normal-vs-Extreme_Weight |
2.582600E-03 |
| Normal-vs-Obese |
5.804700E-03 |
| Normal-vs-Extreme_Obese |
2.274800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.765200E-01 |
| Normal_Weight-vs-Obese |
5.763600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.800800E-01 |
| Extreme_Weight-vs-Obese |
9.460600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.615400E-01 |
| Obese-vs-Extreme_Obese |
4.698200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.370800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.583700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.295000E-03 |
| Normal-vs-Age(81-100Yrs) |
2.236200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.960000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.397200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.834400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.083400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.970200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.978370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.297500E-03 |
| Normal-VS-Type2 PRCC |
1.704060E-02 |
| Normal-VS-KIRP CIMP |
4.384000E-04 |
| Normal-VS-Unclassified PRCC |
9.295100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.573400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.244300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.630400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.956400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.342400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.820200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.632300E-02 |
| Normal-vs-N1 |
7.259500E-03 |
| Normal-vs-N2 |
1.631770E-04 |
| N0-vs-N1 |
3.864400E-01 |
| N0-vs-N2 |
1.346440E-02 |
| N1-vs-N2 |
4.037400E-04 |
|
|
